Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 5275       

    Article Cited by others

ORIGINAL ARTICLE

A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India

Singhal Parul, Dixit Pratima, Singh Pooja, Jaiswal Indu, Singh Mastan, Jain Amita

Year : 2016| Volume: 143| Issue : 3 | Page no: 341-347

   This article has been cited by
 
1 Second Line Injectable Drug Resistance and Associated Genetic Mutations in Newly Diagnosed Cases of Multidrug-Resistant Tuberculosis
Vangala Ramakrishna,Pravin Kumar Singh,Shantanu Prakash,Amita Jain
Microbial Drug Resistance. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 Burden of baseline resistance of Mycobacterium tuberculosis to fluoroquinolones and second-line injectables in central India
Prabha Desikan,Nikita Panwalkar,Shreya Chaudhuri,Zeba Khan,Ram Prakash Punde,Ankur Pauranik,Shaina Beg Mirza,Rajeev Ranjan,Sridhar Anand,K S Sachdeva
Transactions of The Royal Society of Tropical Medicine and Hygiene. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis
Vitthal B Makane,Vagolu Siva Krishna,Eruva Vamshi Krishna,Manjulika Shukla,Balakrishnan Mahizhaveni,Sunil Misra,Sidharth Chopra,Dharmarajan Sriram,Vijayan N Azger Dusthackeer,Haridas B Rode
Future Medicinal Chemistry. 2019;
[Pubmed]  [Google Scholar] [DOI]
4 Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis
Uttam B. Karale,Vagolu Siva Krishna,E. Vamshi Krishna,Amit S. Choudhari,Manjulika Shukla,Vikas R. Gaikwad,B. Mahizhaveni,Sidharth Chopra,Sunil Misra,Dhiman Sarkar,Dharmarajan Sriram,V.N. Azger Dusthackeer,Haridas B. Rode
European Journal of Medicinal Chemistry. 2019;
[Pubmed]  [Google Scholar] [DOI]
5 Synthesis and evaluation of a-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis
Vitthal B. Makane,Vagolu Siva Krishna,E. Vamshi Krishna,Manjulika Shukla,B. Mahizhaveni,Sunil Misra,Sidharth Chopra,Dharmarajan Sriram,V.N. Azger Dusthackeer,Haridas B. Rode
European Journal of Medicinal Chemistry. 2019; 164: 665
[Pubmed]  [Google Scholar] [DOI]
6 Characterization of Mycobacterium tuberculosis strains in Beijing, China: drug susceptibility phenotypes and Beijing genotype family transmission
Yi Liu,Xuxia Zhang,Yuqing Zhang,Yong Sun,Cong Yao,Wei Wang,Chuanyou Li
BMC Infectious Diseases. 2018; 18(1)
[Pubmed]  [Google Scholar] [DOI]
7 First insights on the genetic diversity of MDR Mycobacterium tuberculosis in Lebanon
Balig Panossian,Tamara Salloum,George F. Araj,Georges Khazen,Sima Tokajian
BMC Infectious Diseases. 2018; 18(1)
[Pubmed]  [Google Scholar] [DOI]
8 Pre-Extensively Drug Resistant Tuberculosis (Pre-XDR-TB) among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) Patients in Bangladesh
Tamanna Tasnim,Shirin Tarafder,Fatema Mohammad Alam,Humayun Sattar,S. M. Mostofa Kamal
Journal of Tuberculosis Research. 2018; 06(03): 199
[Pubmed]  [Google Scholar] [DOI]
9 A study on pattern of resistance to second line anti tubercular drugs among multi drug resistant tuberculosis patients
Amit Kumar Sharma,Neeraj Gupta,Dilip Kumar Kala,Tarun Patni,Ramakant Dixit,Satyadeep Verma,Arjun Chandran
Indian Journal of Tuberculosis. 2018;
[Pubmed]  [Google Scholar] [DOI]
10 Baseline resistance and cross-resistance among fluoroquinolones in multidrug-resistant Mycobacterium tuberculosis isolates at a national reference laboratory in India
H.G. Mamatha,V. Shanthi
Journal of Global Antimicrobial Resistance. 2018; 12: 5
[Pubmed]  [Google Scholar] [DOI]
11 Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India
Malaisamy Muniyandi,Rajeswari Ramachandran
Expert Opinion on Pharmacotherapy. 2017; 18(13): 1301
[Pubmed]  [Google Scholar] [DOI]
12 The study on the association between Beijing genotype family and drug susceptibility phenotypes of Mycobacterium tuberculosis in Beijing
Yi Liu,Xiaoying Jiang,Wensheng Li,Xuxia Zhang,Wei Wang,Chuanyou Li
Scientific Reports. 2017; 7(1)
[Pubmed]  [Google Scholar] [DOI]
13 Molecular epidemiology of multi- and extensively-drug-resistant mycobacterium tuberculosis in ireland, 2001-2014
E. Roycroft,R.F. OĉToole,M.M. Fitzgibbon,L. Montgomery,M. OĉMeara,P. Downes,S. Jackson,J. OĉDonnell,I.F. Laurenson,A.M. McLaughlin,J. Keane,T.R. Rogers
Journal of Infection. 2017;
[Pubmed]  [Google Scholar] [DOI]
14 XDR-TB among suspects under programmatic management of drug-resistant TB in northern India
Amita Jain,Pravin Kumar Singh,Vangala Ramakrishna
Journal of Global Antimicrobial Resistance. 2016; 7: 167
[Pubmed]  [Google Scholar] [DOI]

 

Read this article